Home > Boards > US OTC > Biotechs > Enzon Pharmaceuticals Inc. (ENZN)

On August 10, 2017, the Board of Directors

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Carter08 Member Profile
 
Followed By 10
Posts 550
Boards Moderated 0
Alias Born 02/07/17
160x600 placeholder
Carter08   Wednesday, 08/16/17 04:45:32 PM
Re: aquaspin post# 934
Post # of 964 
On August 10, 2017, the Board of Directors of Enzon Pharmaceuticals, Inc. (the “Company”) declared a special cash dividend of $0.15 per share of the
Company’s common stock, payable on September 28, 2017 to stockholders of record as of the close of business on August 30, 2017.

there is only one drug left to receive royalties, not sure when the royalty rights will expire. Maybe the company will regroup after no more royalties?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist